InvestorsHub Logo

Cobra Kai

11/13/13 4:52 PM

#2013 RE: Justfactsmam #2012

I think XXII is nearing its end with Sabby- we will learn more on that soon via filings

They have lots of catalyst- British American milestone payments- clearing out Sabby of course- Pfizer- more licensing agreements- production of their modified risk cig's etc. etc.

just the partner they landed alone should command them a better valuation imo- but they flushed several out recently with Sabby's selling to go with a few small insider sells which didn't help confidence either.

All 3 good plays

slyestjester

11/13/13 7:56 PM

#2014 RE: Justfactsmam #2012

When in doubt it sometimes pays to turn to technical analysis. Now while I have no idea where the price will be in the future, the chart shows the trend that brought the stock from .15 to 1.75 is still intact.

http://finance.yahoo.com/q/bc?s=XXII+Basic+Chart&t=1y